Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy
- 1 July 1998
- journal article
- Published by Springer Nature in Breast Cancer
- Vol. 5 (3) , 211-217
- https://doi.org/10.1007/bf02966699
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tamoxifen: From breast cancer therapy to the design of a postmenopausal prevention maintenance therapyOsteoporosis International, 1997
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal Of Cancer, 1996
- Adjuvant tamoxifen: 5 year control of dormant disease?European Journal Of Cancer, 1996
- Gynecologic effects of tamoxifen and the association with endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 1995
- Should clinicians be concerned about the carcinogenic potential of tamoxifen?European Journal Of Cancer, 1994
- Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communicationJournal of Steroid Biochemistry, 1990
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment, 1987
- IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCERThe Lancet, 1983
- Adjuvant therapy of stage II breast cancerBreast Cancer Research and Treatment, 1981